Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal medicinal treatment for women with suspected cardiac chest pain
NL-OMON20207Not yet recruiting
- Sponsor
- Dijklander Ziekenhuis
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nitroglycerin in angina pectoris (2 arms), sponsored by Dijklander Ziekenhuis. Primary endpoints: Reduced number of episodes of pain or discomfort on the chest and Symptomatic use of sublingual nitroglycerin spray. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
nitroglycerin
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NL-OMON20207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20207.